Mylanta Gelcap Interactions
There are 431 drugs known to interact with Mylanta Gelcap (calcium carbonate / magnesium hydroxide), along with 8 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 11 are major, 362 are moderate, and 58 are minor.
- View all 431 medications that may interact with Mylanta Gelcap
- View Mylanta Gelcap alcohol/food interactions (1)
- View Mylanta Gelcap disease interactions (8)
Most frequently checked interactions
View interaction reports for Mylanta Gelcap (calcium carbonate / magnesium hydroxide) and the medicines listed below.
- acetaminophen
- Aricept (donepezil)
- Bacid (LAC) (lactobacillus acidophilus)
- betamethasone topical
- Bisco-Lax (bisacodyl)
- clindamycin
- Coumadin (warfarin)
- Creon (pancrelipase)
- diltiazem
- docusate
- glucosamine
- hydrochlorothiazide
- Imodium A-D (loperamide)
- Lacri-Lube S.O.P. (ocular lubricant ophthalmic)
- Lacrisert (ocular lubricant ophthalmic)
- Levoxyl (levothyroxine)
- Lidoderm (lidocaine topical)
- Loprox (ciclopirox topical)
- Lotemax (loteprednol ophthalmic)
- Maalox (aluminum hydroxide / magnesium hydroxide / simethicone)
- Miacalcin Nasal (calcitonin)
- Milk of Magnesia (magnesium hydroxide)
- MiraLAX (polyethylene glycol 3350)
- Mucinex (guaifenesin)
- nitrofurantoin
- Os-Cal Calcium+D3 (calcium / vitamin d)
- oxygen
- Phenergan (promethazine)
- Pramosone (hydrocortisone / pramoxine topical)
- Pravachol (pravastatin)
Mylanta Gelcap alcohol/food interactions
There is 1 alcohol/food interaction with Mylanta Gelcap (calcium carbonate / magnesium hydroxide).
Mylanta Gelcap disease interactions
There are 8 disease interactions with Mylanta Gelcap (calcium carbonate / magnesium hydroxide) which include:
- phosphate calcifications
- cardiac contraction/conduction
- malabsorption
- renal dysfunction
- sarcoidosis
- inflammatory bowel disease
- intestinal obstruction disorders
- renal dysfunction
More about Mylanta Gelcap (calcium carbonate / magnesium hydroxide)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.